Niacin Extended-Release Tablets, USP 500mg recall — FDA D-0270-2024
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.
Tesla, Inc. (Tesla) is recalling certain 2012-2023 Model S, 2016-2024 Model X, 2017-2023 Model 3, 2019-2024 Model Y, and 2024 Cybertruck vehicles. An incorrect font size is displayed on the…
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Chemical contamination: presence of benzene
Chemical contamination: presence of benzene
Presence of Particulate Matter; identified as glass
Chemical contamination: presence of benzene
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Chemical Contamination: presence of benzene
Presence of Particulate Matter; identified as glass
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Chemical contamination: presence of benzene
CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene
Chemical contamination: presence of benzene
Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.
Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
Chemical contamination: presence of benzene
Browse recent months with enough recall history for useful comparison.